The relationship between vascularity and cell proliferation in human normal and pathological lesions of the oral cheek epithelium

European Journal of Cancer Part B: Oral Oncology

Volumn 32, Issue 1, 1996, Pages 24-31

  Tipoe, G L ^a   Jin, Y ^a   White, F H ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Blood vessels; Cell proliferation; Human; Morphometry; Oral cancer; PCNA

Indexed keywords

CYCLINE;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MORPHOMETRICS; MOUTH CANCER; PRIORITY JOURNAL; VASCULARIZATION;

EID: 0029920759     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/0964-1955(95)00049-6     Document Type: Article

References (34)

1. Folkman J, Cotran R. Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 1976, 16, 207-248.
2. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987,235, 442-447.
3. Folkman J. Tumor angiogenesis. Adv Cancer Res 1975, 43, 175-203.
4. Klagsbrun M, D'Amore PA. Regulators of angiogenesis. Annu Rev Physiol 1991, 53, 217-239.
5. Rastinejad F, Polverini PJ, Bouck NP. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989, 56, 345-355.
6. Herlyn M, Clark WH, Rodeck U, et al. Biology of tumor progression in human melanocytes. Lab Invest 1987,56,461-474.
7. Weidner N, Semple JP, Welch WR, Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. New EnglJ Med 1991, 324, 1-8.
8. Waseem NH, Lane DP. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sei 1990, 96, 121-129.
9. Siitonen SM, Kallioniemi O-P, Isola JJ. PCNA immunohistochemistry using MoAb 19A2 and new antigen retrieval has prognostic impact in archival paraffin-embedded node-negative breast cancer. Am y Pathol 1993,142, 1081-1090.
10. Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990,162, 285-294.
11. Haapasalo, HK, Sallinen, PK, Helen PT, et al. Comparison of three quantitation methods for PCNA immunostaining: applicability and relation to survival in 83 astrocytic neoplasms. J Pathol 1993, 171, 207-214.
12. Pendleton N, Dixon GR, Burnett HE, et al. Expression of proliferating cell nuclear antigen (PCNA) in dysplasia of the bronchial epithelium. J Pathol 1993, 170, 169-172.
13. Budke H, Orazi A, Neiman RS, Cattoretti G, John K, Barberis M. Assessment of cell proliferation in paraffin sections of normal bone marrow by monoclonal antibodies Ki-67 and PCNA. Mod Pathol 1994, 7, 860-866.
14. Bryne M, Koppang HS, Lilleng R, Stene T, Bang G, Dabelsteen EJ. New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol Med 1989, 18, 432-437.
15. Jin Y, White FH, Yang L. A histological morphometric study of nuclear size in benign and malignant neoplasms of human cheek. Histopathology 1993, 23, 271-274.
16. White FH, Jin Y, Yang L. Quantitative cellular and nuclear volumetric alterations in epithelium from lichen planus lesions of human buccal mucosa. J Oral Pathol Med 1994, 23, 205-208.
17. Weibel ER. Stereological methods. In Practical Methods for Biological Morphometry, Vol. 1. London, Academic Press, 1979.
18. Hally AD. A counting method for measuring the volumes of tissue components in microscopical sections. Quart J Microsc Sei 1964, 105, 503-517.
19. Duncan DB. Multiple range and multiple F tests. Biometrics 1955, 11, 1-42.
20. Spearman C. The proof and measurement of association between two things. Am Statist 1904, 15, 72-101.
21. Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using PCNA/cyclin monoclonal antibodies in fixed, embedded tissues-comparison with flow cytometric analysis. Am J Pathol 1989, 134, 733-739.
22. Dierendock JHV, Wijsman RK, Keizer R, Velde CJH van de, Cornelisse CJ. Cell cycle related staining pattern of antibodies: comparison with BrdU labeling and Ki67 staining. Am J Pathol 1991,138,1165-1172.
23. Shivji MKK, Kenny MK, Wood RD. Proliferating cell nuclear antigen (PCNA) is required for DNA excision repair. Cell 1991, 69, 367-374.
24. McCormick D, Yu C, Hobbs C, Hall PA. The relevance of antibody concentration to the immunohistological quantitation of cell proliferation associated antigens. Histopathology 1993, 22, 543-547.
25. Wright A, Shear M. Epithelial dysplasia immediately adjacent to oral squamous cell carcinomas. J Oral Pathol 1985,14, 559-564.
26. Delahunt B, Bethwaite PB, Nacey JN, Ribas JL. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers. J Pathol 1993, 170, 471-477.
27. Cattoretti G, Becker MHG, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed sections. J Pathol 1992, 168, 357-363.
28. FrankeWW, Schmid E, Osborn M, Weber K. Intermediate-sized filaments of human endothelial cells. J Cell Biol 1979, 81, 570-580.
29. Drenckhahn D. Cell motility and cytoplasmic filaments in vascular endothelium. Prog Appl Microcirc 1983,1, 53-70.
30. Steinert PM, Jones JCR, Goldman RD. Intermediate filaments. J Cell Biol 1984, 99, 22-27.
31. Wakui S, Furusata M, Itoh T, et al. Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 1992, 168, 257-262.
32. White FH, Al-Azzawi B. Vascularity in experimental oral neoplasia: a stereological approach. Acta Stereol 1983,2,119-126.
33. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990, 82, 4-6.
34. Li DeChun, Bell J, Brown A, Berry C. The observation of angiogenin and basic fibroblast growth factor gene expression in human colonie adenocarcinomas, gastric adenocarcinomas, and hepatocellular carcinomas. J Pathol 1994, 172, 171-175.